Back | Next |
home / stock / rnugf / rnugf message board
Subject | By | Source | When |
---|---|---|---|
I expect $10.00 or more per share before | georgejjl | investorshub | 05/21/2019 12:15:28 AM |
Will do. | georgejjl | investorshub | 05/21/2019 12:05:12 AM |
Major Shareholdings: | georgejjl | investorshub | 05/21/2019 12:01:26 AM |
Please feel free to alert me private if | JUST 10-11-12 | investorshub | 05/20/2019 11:58:50 PM |
Just 10-11-12 | georgejjl | investorshub | 05/20/2019 11:54:26 PM |
hRPC moves to centre stage | georgejjl | investorshub | 05/20/2019 11:40:10 PM |
Going to need those to push it to ten. | JUST 10-11-12 | investorshub | 05/19/2019 7:56:17 PM |
Wish institutions were on board? | JUST 10-11-12 | investorshub | 05/19/2019 5:22:17 PM |
ReNeuron Group primed for a pivotal 18 month | georgejjl | investorshub | 05/11/2019 4:35:51 PM |
RNUGF stock price could easily exceed $10 per | georgejjl | investorshub | 05/03/2019 2:48:29 PM |
Latest presentation | georgejjl | investorshub | 05/03/2019 12:37:26 PM |
ReNeuron is presenting at the following events. | georgejjl | investorshub | 05/03/2019 12:23:13 PM |
ARVO 2019 Highlight: RP Patients in ReNeurons Cell | georgejjl | investorshub | 04/30/2019 12:21:28 AM |
Expect more news this week!!! | georgejjl | investorshub | 04/28/2019 1:17:54 PM |
ARVO 2019 Annual Meeting is Sunday April 28 | georgejjl | investorshub | 04/27/2019 10:07:51 PM |
Reneuron http://www.reneuron.com/ Good luck and GOD bless, | georgejjl | investorshub | 04/27/2019 2:16:05 PM |
The Company is aware of the following significant | georgejjl | investorshub | 04/27/2019 2:02:23 PM |
ReNeuron Group Plc (RENE) Insider Buys £180,000 in Stock | georgejjl | investorshub | 04/27/2019 1:57:39 PM |
stem cell researcher Reneuron up 22% due to | georgejjl | investorshub | 04/27/2019 1:52:15 PM |
Reneuron has a trial for treating ischemic stroke | georgejjl | investorshub | 04/27/2019 1:17:38 PM |
News, Short Squeeze, Breakout and More Instantly...
ReNeuron Group Company Name:
RNUGF Stock Symbol:
OTCMKTS Market:
(NewsDirect) ReNeuron Group PLC executive chairman Iain Ross tells Proactive that the company is focused on generating in vivo data and validating its exosome delivery technology platform CustomEX as 2023 gets underway. ReNeuron will conduct head-to-head studies with its competitors to pr...
LONDON, UK / ACCESSWIRE / October 10, 2022 / ReNeuron Group, a stem cell-derived exosome technology company, has presented encouraging preclinical data highlighting the enhanced drug delivery capability of its customisable exosome platform (CustomEx) over conventional human embryonic kidney-...
LONDON, UK / ACCESSWIRE / October 11, 2021 / ReNeuron has announced that the nine-patient Phase IIa (2m cell dose) extension study (halted in June after a presumed eye infection case) has fully restarted with five patients left to treat. Two patients are scheduled for treatment in October. T...